Beth Hecht
Chief Legal Officer and Corporate Secretary · Xeris Biopharma Holdings, Inc.
- 2025
- Oct 2, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Beth Hecht files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kevin McCulloch - $1.36M in XERS purchases and sales in the last 12 months
- Steven Pieper - $515K in XERS purchases and sales in the last 12 months
- John Patrick Shannon Jr. - $173K in XERS purchases and sales in the last 12 months
- Dawn Halkuff - $122K in XERS purchases and sales in the last 12 months
- Barbara-Jean Anne Bormann-Kennedy - $98K in XERS purchases and sales in the last 12 months
- Marla Persky - $91K in XERS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Beth Hecht?
Beth Hecht is a corporate insider, tracked as Chief Legal Officer and Corporate Secretary of Xeris Biopharma Holdings, Inc. (XERS). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Beth Hecht submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Beth Hecht been buying or selling stock?
Recorded transactions: 0 open-market purchases and 12 open-market sales ($1.34M) across all tracked filings.
